Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of the diagnostic value of [68 Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in patients with T stage ≤ 2a2 uterine cervical cancer: a prospective study.
Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1163-1172. doi: 10.1007/s00259-023-06539-z. Epub 2023 Nov 30.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 38032383
A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer.
Xi Y, Sun L, Che X, Huang X, Liu H, Wang Q, Meng H, Miao Y, Qu Q, Hai W, Li B, Feng W.
Xi Y, et al.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2885-2898. doi: 10.1007/s00259-023-06235-y. Epub 2023 Apr 24.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37093313
Item in Clipboard
Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J, Li Y, Liu H, Zhang J, Wang J, Xia J, Zhang Y, Yu X, Ma J, Huang M, Wang J, Wang L, Li Q, Cui R, Yang W, Xu Y, Feng W.
Zhang J, et al.
J Exp Clin Cancer Res. 2022 Jan 15;41(1):24. doi: 10.1186/s13046-022-02242-3.
J Exp Clin Cancer Res. 2022.
PMID: 35033172
Free PMC article.
Item in Clipboard
Cite
Cite